HC2 Holdings Reports Second Quarter 2020 Results
- Second Quarter 2020 Consolidated Net Revenue of
- Completes Sale of 30% Interest in HMN Joint Venture, Reducing Debt -
Second Quarter 2020 Highlights
- Redeemed approximately
$50 .6 million of HC2’s 11.5% Senior Secured Notes. - Net Income attributable to common and participating preferred stockholders of
$12.7 million , or$0.26 per share, compared to$9.0 million , or$0.12 per fully diluted share, in the year-ago quarter. Net Income for the second quarter 2019 includes a$0.12 per share loss from discontinued operations. - Adjusted EBITDA for Core Operating Subsidiaries* of
$23.5 million , compared to$25.2 million in the year-ago quarter. - Total Adjusted EBITDA, excluding Insurance, of
$15.2 million , compared to$25.5 million in the year-ago quarter.
* “Core Operating Subsidiaries” consists of HC2’s Construction, Energy and Telecommunications segments.
Subsequent Event
- Announced pursuit of strategic options for Telecommunications subsidiary,
PTGi-International Carrier Services, Inc.
“We continued to navigate through the challenging environment caused by the COVID-19 pandemic, and I am proud of our team’s ongoing efforts to ensure our businesses run as smoothly as possible while adhering to the highest standards in providing quality service to all of our customers,” stated
“We were pleased our Energy subsidiary tripled its Adjusted EBITDA compared to the prior-year period, and we are excited for the impending commercial launch of R2’s CryoAesthetic technology within the next few months,” added
Second Quarter Financial Highlights
- Net Revenue: For the second quarter of 2020, HC2 consolidated net revenue was
$377.0 million , compared to$479.2 million for the year-ago quarter. Lower revenues from the Telecommunications, Construction and Broadcasting segments, as well as the Insurance segment, net of eliminations, were partially offset by an increase in revenue from the Energy segment.
NET REVENUE by OPERATING SEGMENT | ||||||||||||||||||||||||||||||
(in millions) | Three Months Ended |
Six Months Ended |
||||||||||||||||||||||||||||
2020 | 2019 | Increase / (Decrease) |
2020 | 2019 | Increase / (Decrease) |
|||||||||||||||||||||||||
Construction | $ | 172.3 | $ | 195.7 | $ | (23.4 | ) | $ | 348.8 | $ | 387.8 | $ | (39.0 | ) | ||||||||||||||||
Energy | 10.3 | 5.5 | 4.8 | 20.7 | 10.6 | 10.1 | ||||||||||||||||||||||||
Telecommunications | 107.3 | 189.3 | (82.0 | ) | 293.7 | 344.8 | (51.1 | ) | ||||||||||||||||||||||
Total Core Operating Subsidiaries | $ | 289.9 | $ | 390.5 | $ | (100.6 | ) | $ | 663.2 | $ | 743.2 | $ | (80.0 | ) | ||||||||||||||||
Insurance | 80.5 | 82.1 | (1.6 | ) | 144.3 | 170.9 | (26.6 | ) | ||||||||||||||||||||||
Broadcasting | 9.5 | 10.0 | (0.5 | ) | 19.6 | 19.8 | (0.2 | ) | ||||||||||||||||||||||
Eliminations (1) | (2.9 | ) | (3.4 | ) | 0.5 | (5.3 | ) | (5.7 | ) | 0.4 | ||||||||||||||||||||
Consolidated HC2 | $ | 377.0 | $ | 479.2 | $ | (102.2 | ) | $ | 821.8 | $ | 928.2 | $ | (106.4 | ) |
(1) The Insurance segment revenues are inclusive of realized and unrealized gains and net investment income for the three and six months ended
- Net Income / (Loss): For the second quarter of 2020, HC2 reported Net Income attributable to common stock and participating preferred stockholders of
$12.7 million , or$0.26 per share, compared to$9.0 million , or$0.12 per share, in the year-ago quarter. Net Income attributable to common and participating preferred stockholders per share for the second quarter 2019 includes net loss from discontinued operations of$0.12 per share.
NET INCOME (LOSS) by OPERATING SEGMENT | ||||||||||||||||||||||||||||||
(in millions) | Three Months Ended |
Six Months Ended |
||||||||||||||||||||||||||||
2020 | 2019 | Increase / (Decrease) |
2020 | 2019 | Increase / (Decrease) |
|||||||||||||||||||||||||
Construction | $ | 1.6 | $ | 8.9 | $ | (7.3 | ) | $ | 1.5 | $ | 11.0 | $ | (9.5 | ) | ||||||||||||||||
Energy | 0.4 | (0.7 | ) | 1.1 | 1.0 | (1.3 | ) | 2.3 | ||||||||||||||||||||||
Telecommunications | (0.1 | ) | 0.4 | (0.5 | ) | 0.5 | 1.0 | (0.5 | ) | |||||||||||||||||||||
Total Core Operating Subsidiaries | $ | 1.9 | $ | 8.6 | $ | (6.7 | ) | $ | 3.0 | $ | 10.7 | $ | (7.7 | ) | ||||||||||||||||
Insurance | 11.4 | 30.3 | (18.9 | ) | 11.4 | 64.1 | (52.7 | ) | ||||||||||||||||||||||
Life Sciences | (1.2 | ) | (1.4 | ) | 0.2 | (4.4 | ) | (4.0 | ) | (0.4 | ) | |||||||||||||||||||
Broadcasting | (4.7 | ) | (3.5 | ) | (1.2 | ) | (10.9 | ) | (7.9 | ) | (3.0 | ) | ||||||||||||||||||
Other and Eliminations | 46.1 | 1.1 | 45.0 | 4.0 | (4.7 | ) | 8.7 | |||||||||||||||||||||||
Non-operating Corporate | (38.9 | ) | (22.5 | ) | (16.4 | ) | (70.0 | ) | (46.1 | ) | (23.9 | ) | ||||||||||||||||||
Consolidating Eliminations attributable to HC2 Holdings Insurance Segment(1) | (1.5 | ) | (3.2 | ) | 1.7 | (3.1 | ) | (5.5 | ) | 2.4 | ||||||||||||||||||||
Net income (loss) attributable to |
$ | 13.1 | $ | 9.4 | $ | 3.7 | $ | (70.0 | ) | $ | 6.6 | $ | (76.6 | ) | ||||||||||||||||
Less: Preferred dividends, deemed dividends, and repurchase gains | 0.4 | 0.4 | — | 0.8 | (0.8 | ) | 1.6 | |||||||||||||||||||||||
Net income (loss) attributable to common stock and participating preferred stockholders | $ | 12.7 | $ | 9.0 | $ | 3.7 | $ | (70.8 | ) | $ | 7.4 | $ | (78.2 | ) |
(1) The Insurance segment results are inclusive of realized and unrealized gains and net investment income for the three and six months ended
- Adjusted EBITDA: Adjusted EBITDA for “Core Operating Subsidiaries” totaled
$23.5 million for the second quarter of 2020, compared to$25.2 million for the year-ago quarter, as improvements at Energy were offset by reduced contributions from Construction and Telecommunications.
For the second quarter of 2020, Total Adjusted EBITDA, which excludes the Insurance segment, totaled$15.2 million , compared to Adjusted EBITDA of$25.5 million for the year-ago quarter. The year-over-year decrease was primarily due to reduced contributions from the Other segment, which now consists of equity income from the 19% piece of the HMN joint venture the Company owns, plus increased losses at the Life Sciences and Broadcasting segments. The decline in the Other segment from the prior-year period was due to lower profits at the HMN joint venture due to timing of turnkey project work.
ADJUSTED EBITDA by OPERATING SEGMENT | |||||||||||||||||||||||||||||
(in millions) | Three Months Ended |
Six Months Ended |
|||||||||||||||||||||||||||
2020 | 2019 | Increase / (Decrease) |
2020 | 2019 | Increase / (Decrease) |
||||||||||||||||||||||||
Construction | $ | 19.1 | $ | 23.1 | $ | (4.0 | ) | $ | 28.1 | $ | 35.5 | $ | (7.4 | ) | |||||||||||||||
Energy | 4.2 | 1.3 | 2.9 | 8.0 | 2.3 | 5.7 | |||||||||||||||||||||||
Telecommunications | 0.2 | 0.8 | (0.6 | ) | 0.6 | 1.6 | (1.0 | ) | |||||||||||||||||||||
Total Core Operating Subsidiaries | $ | 23.5 | $ | 25.2 | $ | (1.7 | ) | $ | 36.7 | $ | 39.4 | $ | (2.7 | ) | |||||||||||||||
Life Sciences | (4.5 | ) | (1.8 | ) | (2.7 | ) | (8.7 | ) | (4.7 | ) | (4.0 | ) | |||||||||||||||||
Broadcasting | (1.1 | ) | (0.9 | ) | (0.2 | ) | (2.1 | ) | (3.4 | ) | 1.3 | ||||||||||||||||||
Other and Eliminations | 0.9 | 7.4 | (6.5 | ) | (0.7 | ) | 2.5 | (3.2 | ) | ||||||||||||||||||||
Non-operating Corporate | (3.6 | ) | (4.4 | ) | 0.8 | (8.6 | ) | (10.5 | ) | 1.9 | |||||||||||||||||||
Total Adjusted EBITDA | $ | 15.2 | $ | 25.5 | $ | (10.3 | ) | $ | 16.6 | $ | 23.3 | $ | (6.7 | ) |
- Balance Sheet: As of
June 30, 2020 , HC2 had consolidated cash, cash equivalents and investments of$4.6 billion , which includes cash and investments associated with HC2’s Insurance segment. Excluding the Insurance segment, consolidated cash was$64.3 million , of which$0.9 million was at the HC2 corporate level.
Second Quarter 2020 Segment Highlights
- Construction
- The Company continues to review strategic alternatives for DBM, including a potential sale or a subsidiary refinancing.
- For the second quarter of 2020, DBM reported Net Income of
$1.6 million , compared to$8.9 million for the year-ago quarter. Adjusted EBITDA was$19.1 million , compared to$23.1 million in the year-ago quarter. DBM’s results for the quarter were impacted by the timing and mix of project backlog, as well as from the COVID-19 pandemic, which has resulted in delays in new project awards for both its commercial construction and industrial services businesses. DBM was further impacted by certain industrial services customers electing to defer on routine maintenance and repair until a future date, and in some cases indefinitely defer or cancel new capital projects, in response to the lower demand in oil and gas markets.
- DBM's total backlog was approximately
$410.3 million as ofJune 30, 2020 , compared to$468.5 million for the year-ago quarter. Taking into consideration awarded, but not yet signed contracts, backlog would have been approximately$714 million at the end of the second quarter of 2020, compared to$662 million at the end of the second quarter of 2019.
- The Company continues to review strategic alternatives for DBM, including a potential sale or a subsidiary refinancing.
- Energy
- For the second quarter of 2020, ANG reported Net Income of
$0.4 million , compared to a Net Loss of$0.7 million for the year-ago quarter. Adjusted EBITDA increased to$4.2 million compared to$1.3 million for the year-ago quarter, driven by contributions from ANG’sJune 2019 acquisition of 20 ampCNG fueling stations, as well as from the Alternative Fuel Tax Credit, which was not yet approved for 2019 in the year-ago quarter.
- For the second quarter of 2020, ANG reported Net Income of
- Broadcasting
- During 2020,
HC2 Broadcasting has entered into agreements with a number of recognizable name brand content providers, including DABL, a CBS Diginet,Cheddar News , and LX Network, an NBC Universal Diginet.
- As of early
August 2020 , HC2’s Broadcasting segment has 233 operational stations, of which approximately 190 are currently connected to the Company’s CentralCast system, in 95 Designated Market Areas (“DMAs”) acrossthe United States andPuerto Rico , including active operating stations in 34 of the top 35 DMAs. The remaining silent license builds are expected to be completed during the third quarter, and the Company's stations will be approximately 98 DMAs once complete.
- During 2020,
- Life Sciences
- In
April 2020 ,R2 Technologies (“R2”) received an additional$10 million equity investment from Huadong Medicine Company Limited (“Huadong”), R2’s exclusive distributor in theChina /Asia-Pacific market. This represents the second tranche of Huadong’s investment in R2 at an approximate post-money valuation of$90 million . Proceeds from the new equity investment in R2 are being utilized to commercialize R2’s FDA-approved revolutionary CryoAesthetic technology, which promises physicians a new way to treat aesthetic and medical skin conditions.
- R2 plans to commence its pre-order process in the third quarter, barring any COVID-related delays, in advance of a fourth quarter or early 2021 launch. As a reminder, both R2 and MediBeacon are fully funded for ongoing activities, and as a result, the Company currently does not anticipate a need for further capital investment from HC2.
- In
- Insurance
- The Company continues to review strategic alternatives for Continental, including a potential sale.
- As of
June 30, 2020 , Continental had$4.5 billion of cash and invested assets,$5.7 billion in total GAAP assets, and an estimated$360 million of total adjusted capital.
- For the second quarter of 2020, Continental reported Net Income of
$11.4 million , compared to$30.3 million for the year-ago quarter.
- Pre-Tax Insurance AOI was
$14.6 million for the second quarter of 2020, compared to Pre-Tax Insurance AOI of$33.0 million for the year-ago quarter. The decrease was primarily driven by non-recurring favorable claims activity recognized in the year-ago quarter driven by an increase in contingent non-forfeiture option activity as a result of in-force rate actions approved and implemented, and additional unfavorable claims activity and reserve developments in the current year. Additionally, the Insurance segment incurred larger expenses due to additional premium taxes, miscellaneous software expenses, third party management fees, and legal expenses.
- The Company continues to review strategic alternatives for Continental, including a potential sale.
Conference Call
Dial-in instructions for the conference call and the replay are as follows:
Live Webcast and Call
A live webcast of the conference call can be accessed by interested parties through the Investor Relations section of the HC2 Website at ir.hc2.com.
Domestic Dial-In (Toll Free): 1-877-705-6003 or International Dial-In: 1-201-493-6725
Participant Entry Number: 13707250
Conference Replay*
Domestic Dial-In (Toll Free): 1-844-512-2921 or International Dial-In: 1-412-317-6671
Conference Number: 13707250
*Available approximately two hours after the end of the conference call through
About HC2
Contact
Investor Relations
ICR
Phone: (212) 235-2691
E-mail: ir@hc2.com
Non-GAAP Financial Measures
In this press release, HC2 refers to certain financial measures that are not presented in accordance with
Adjusted EBITDA
Management believes that Adjusted EBITDA provides investors with meaningful information for gaining an understanding of our results as it is frequently used by the financial community to provide insight into an organization’s operating trends and facilitates comparisons between peer companies, since interest, taxes, depreciation, amortization and the other items listed in the definition of Adjusted EBITDA below can differ greatly between organizations as a result of differing capital structures and tax strategies. Adjusted EBITDA can also be a useful measure of a company’s ability to service debt. While management believes that non-
The calculation of Adjusted EBITDA, as defined by us, consists of Net income (loss) as adjusted for depreciation and amortization; Other operating (income) expense, which is inclusive of (gain) loss on sale or disposal of assets, lease termination costs, and
To help our board, management and investors assess the impact of COVID-19 pandemic on our results of operations, we are excluding the impacts of COVID-19 response initiatives for the cost of personal protective equipment distributed to employees, cleaning and sanitization equipment and procedures, and additional overhead costs to maintain proper social distancing from Adjusted EBITDA. Our board and management find the exclusion of the impact of these COVID-19 response initiatives from Adjusted EBITDA to be useful because it allows us and our investors to assess the impact of these response initiatives on our results of operations.
Management recognizes that using Adjusted EBITDA as a performance measure has inherent limitations as an analytical tool as compared to net income (loss) or other GAAP financial measures, as these non-GAAP measures exclude certain items, including items that are recurring in nature, which may be meaningful to investors.
Adjusted Operating Income - Insurance
Adjusted Operating Income (“Insurance AOI”) and Pre-tax Adjusted Operating Income (“Pre-tax Insurance AOI”) for the Insurance segment are non-U.S. GAAP financial measures frequently used throughout the insurance industry and are economic measures the Insurance segment uses to evaluate its financial performance. Management believes that Insurance AOI and Pretax Insurance AOI measures provide investors with meaningful information for gaining an understanding of certain results and provide insight into an organization’s operating trends and facilitates comparisons between peer companies. However, Insurance AOI and Pre-tax Insurance AOI have certain limitations, and we may not calculate it the same as other companies in our industry. It should, therefore, be read together with the Company's results calculated in accordance with
Similarly to Adjusted EBITDA, using Insurance AOI and Pre-tax Insurance AOI as performance measures have inherent limitations as an analytical tool as compared to income (loss) from operations or other
Management defines Insurance AOI as Net income (loss) for the Insurance segment adjusted to exclude the impact of net investment gains (losses), including OTTI losses recognized in operations; asset impairment; intercompany elimination; bargain purchase gains; reinsurance gains; and acquisition costs. Management defines Pre-tax Insurance AOI as Insurance AOI adjusted to exclude the impact of income tax (benefit) expense recognized during the current period. Management believes that Insurance AOI and Pre-tax Insurance AOI provide meaningful financial metrics that help investors understand certain results and profitability. While these adjustments are an integral part of the overall performance of the Insurance segment, market conditions impacting these items can overshadow the underlying performance of the business. Accordingly, we believe using a measure which excludes their impact is effective in analyzing the trends of our operations.
Cautionary Statement Regarding Forward-Looking Statements
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This press release contains, and certain oral statements made by our representatives from time to time may contain, forward-looking statements, including, among others, statements related to the expected or potential impact of the novel coronavirus (COVID-19) pandemic, and the related responses of the government and HC2 on our business, financial condition and results of operations, and any such forward-looking statements, whether concerning the COVID-19 pandemic or otherwise, involve risks, assumptions and uncertainties. Generally, forward-looking statements include information describing actions, events, results, strategies and expectations and are generally identifiable by use of the words “believes,” “expects,” “intends,” “anticipates,” “plans,” “seeks,” “estimates,” “projects,” “may,” “will,” “could,” “might,” or “continues” or similar expressions. The forward-looking statements in this press release include, without limitation, any statements regarding our expectations regarding entering definitive agreements in respect of the potential divestitures of
The Company believes these judgments are reasonable, but you should understand that these statements are not guarantees of performance or results, and the Company’s actual results could differ materially from those expressed or implied in the forward-looking statements due to a variety of important factors, both positive and negative, that may be revised or supplemented in subsequent statements and reports filed with the
Although HC2 believes its expectations and assumptions regarding its future operating performance are reasonable, there can be no assurance that the expectations reflected herein will be achieved. There can be no assurance that definitive agreements for potential divestitures or other strategic transactions will be entered into with respect to
You should not place undue reliance on forward-looking statements. All forward-looking statements attributable to HC2 or persons acting on its behalf are expressly qualified in their entirety by the foregoing cautionary statements. All such statements speak only as of the date made, and unless legally required, HC2 undertakes no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(in millions, except per share amounts)
(Unaudited)
Three Months Ended |
Six Months Ended |
|||||||||||||||||||
2020 | 2019 | 2020 | 2019 | |||||||||||||||||
Revenue | $ | 299.4 | $ | 400.5 | $ | 682.8 | $ | 763.0 | ||||||||||||
Life, accident and health earned premiums, net | 29.6 | 29.9 | 58.2 | 59.8 | ||||||||||||||||
Net investment income | 48.5 | 50.3 | 100.4 | 101.4 | ||||||||||||||||
Net realized and unrealized gains (losses) on investments | (0.5 | ) | (1.5 | ) | (19.6 | ) | 4.0 | |||||||||||||
Net revenue | 377.0 | 479.2 | 821.8 | 928.2 | ||||||||||||||||
Operating expenses | ||||||||||||||||||||
Cost of revenue | 262.1 | 350.6 | 608.2 | 675.1 | ||||||||||||||||
Policy benefits, changes in reserves, and commissions | 63.0 | 48.0 | 135.4 | 100.7 | ||||||||||||||||
Selling, general and administrative | 48.1 | 46.2 | 100.4 | 93.1 | ||||||||||||||||
Depreciation and amortization | 1.1 | 1.2 | 1.7 | 1.5 | ||||||||||||||||
Other operating income | (2.2 | ) | (0.4 | ) | (2.0 | ) | (1.4 | ) | ||||||||||||
Total operating expenses | 372.1 | 445.6 | 843.7 | 869.0 | ||||||||||||||||
Income (loss) from operations | 4.9 | 33.6 | (21.9 | ) | 59.2 | |||||||||||||||
Interest expense | (21.4 | ) | (19.1 | ) | (42.7 | ) | (37.9 | ) | ||||||||||||
Loss on early extinguishment or restructuring of debt | (3.4 | ) | — | (9.2 | ) | — | ||||||||||||||
(Loss) income from equity investees | (0.2 | ) | 7.2 | (2.7 | ) | 1.3 | ||||||||||||||
Gain on bargain purchase | — | 1.1 | — | 1.1 | ||||||||||||||||
Other income (loss) | 64.0 | (4.8 | ) | 66.8 | (1.4 | ) | ||||||||||||||
Income (loss) from continuing operations | 43.9 | 18.0 | (9.7 | ) | 22.3 | |||||||||||||||
Income tax expense | (15.4 | ) | (1.1 | ) | (2.8 | ) | (5.1 | ) | ||||||||||||
Income (loss) from continuing operations | 28.5 | 16.9 | (12.5 | ) | 17.2 | |||||||||||||||
Loss from discontinued operations (including loss on disposal of |
— | (7.7 | ) | (60.0 | ) | (14.3 | ) | |||||||||||||
Net income (loss) | 28.5 | 9.2 | (72.5 | ) | 2.9 | |||||||||||||||
Net (income) loss attributable to noncontrolling interest and redeemable noncontrolling interest | (15.4 | ) | 0.2 | 2.5 | 3.7 | |||||||||||||||
Net income (loss) attributable to |
13.1 | 9.4 | (70.0 | ) | 6.6 | |||||||||||||||
Less: Preferred dividends, deemed dividends and repurchase gains | 0.4 | 0.4 | 0.8 | (0.8 | ) | |||||||||||||||
Net income (loss) attributable to common stock and participating preferred stockholders | $ | 12.7 | $ | 9.0 | $ | (70.8 | ) | $ | 7.4 | |||||||||||
Income (loss) per share - continuing operations | ||||||||||||||||||||
Basic: | $ | 0.26 | $ | 0.34 | $ | (0.56 | ) | $ | 0.42 | |||||||||||
Diluted: | $ | 0.26 | $ | 0.24 | $ | (0.56 | ) | $ | 0.28 | |||||||||||
Loss per share - discontinued operations | ||||||||||||||||||||
Basic: | $ | — | $ | (0.15 | ) | $ | (0.97 | ) | $ | (0.27 | ) | |||||||||
Diluted: | $ | — | $ | (0.12 | ) | $ | (0.97 | ) | $ | (0.20 | ) | |||||||||
Income (loss) per share - Net income (loss) attributable to participating securities | ||||||||||||||||||||
Basic: | $ | 0.26 | $ | 0.19 | $ | (1.53 | ) | $ | 0.15 | |||||||||||
Diluted: | $ | 0.26 | $ | 0.12 | $ | (1.53 | ) | $ | 0.08 | |||||||||||
Weighted average common shares outstanding: | ||||||||||||||||||||
Basic: | 46.8 | 45.6 | 46.3 | 45.2 | ||||||||||||||||
Diluted: | 46.9 | 58.1 | 46.3 | 59.9 |
CONDENSED CONSOLIDATED BALANCE SHEET
(in millions, except share amounts)
(Unaudited)
2020 |
2019 |
|||||||
Assets | ||||||||
Investments: | ||||||||
Fixed maturity securities, available-for-sale at fair value | $ | 4,116.3 | $ | 4,028.9 | ||||
Equity securities | 73.8 | 92.5 | ||||||
Mortgage loans | 128.8 | 183.5 | ||||||
Policy loans | 18.5 | 19.1 | ||||||
Other invested assets | 60.8 | 68.1 | ||||||
Total investments | 4,398.2 | 4,392.1 | ||||||
Cash and cash equivalents | 203.8 | 228.8 | ||||||
Accounts receivable, net | 261.2 | 311.8 | ||||||
Recoverable from reinsurers | 958.4 | 953.7 | ||||||
Deferred tax asset | 2.2 | 2.7 | ||||||
Property, plant and equipment, net | 220.2 | 223.7 | ||||||
112.6 | 112.5 | |||||||
Intangibles, net | 218.2 | 221.7 | ||||||
Assets held for sale | — | 323.3 | ||||||
Other assets | 258.5 | 188.0 | ||||||
Total assets | $ | 6,633.3 | $ | 6,958.3 | ||||
Liabilities, temporary equity and stockholders’ equity | ||||||||
Life, accident and health reserves | $ | 4,608.8 | $ | 4,567.1 | ||||
Annuity reserves | 233.1 | 236.4 | ||||||
Value of business acquired | 209.6 | 221.1 | ||||||
Accounts payable and other current liabilities | 283.0 | 306.2 | ||||||
Deferred tax liability | 101.6 | 83.7 | ||||||
Debt obligations | 633.8 | 773.6 | ||||||
Liabilities held for sale | — | 153.9 | ||||||
Other liabilities | 179.5 | 151.1 | ||||||
Total liabilities | 6,249.4 | 6,493.1 | ||||||
Commitments and contingencies | ||||||||
Temporary equity | ||||||||
Preferred stock | 10.3 | 10.3 | ||||||
Redeemable noncontrolling interest | 8.4 | 11.3 | ||||||
Total temporary equity | 18.7 | 21.6 | ||||||
Stockholders’ equity | ||||||||
Common stock, |
— | — | ||||||
Shares authorized: 80,000,000 at |
||||||||
Shares issued: 47,660,135 and 46,810,676 at |
||||||||
Shares outstanding: 46,550,384 and 46,067,852 at |
||||||||
Additional paid-in capital | 288.5 | 281.1 | ||||||
(4.2 | ) | (3.3 | ) | |||||
Accumulated deficit | (166.7 | ) | (96.7 | ) | ||||
Accumulated other comprehensive income (loss) | 201.7 | 168.7 | ||||||
319.3 | 349.8 | |||||||
Noncontrolling interest | 45.9 | 93.8 | ||||||
Total stockholders’ equity | 365.2 | 443.6 | ||||||
Total liabilities, temporary equity and stockholders’ equity | $ | 6,633.3 | $ | 6,958.3 |
RECONCILIATION OF NET INCOME (LOSS) TO ADJUSTED EBITDA
(Unaudited)
(in millions) | Three Months Ended |
||||||||||||||||||||||||||||||||
Core Operating Subsidiaries | Early Stage & Other | Non- operating Corporate |
HC2 | ||||||||||||||||||||||||||||||
Construction | Energy | Telecom | Life Sciences |
Broadcasting | Other and Eliminations |
||||||||||||||||||||||||||||
Net income attributable to |
$ | 13.1 | |||||||||||||||||||||||||||||||
Less: Net income attributable to |
11.4 | ||||||||||||||||||||||||||||||||
Less: Consolidating eliminations attributable to |
(1.5 | ) | |||||||||||||||||||||||||||||||
Net Income (loss) attributable to |
$ | 1.6 | $ | 0.4 | $ | (0.1 | ) | $ | (1.2 | ) | $ | (4.7 | ) | $ | 46.1 | $ | (38.9 | ) | $ | 3.2 | |||||||||||||
Adjustments to reconcile net income (loss) to Adjusted EBITDA: | |||||||||||||||||||||||||||||||||
Depreciation and amortization | 2.7 | 2.0 | 0.1 | 0.1 | 1.7 | — | — | 6.6 | |||||||||||||||||||||||||
Depreciation and amortization (included in cost of revenue) | 2.3 | — | — | — | — | — | — | 2.3 | |||||||||||||||||||||||||
Other operating (income) expenses | (0.1 | ) | — | — | — | (2.1 | ) | — | — | (2.2 | ) | ||||||||||||||||||||||
Interest expense | 2.2 | 1.2 | — | — | 3.5 | — | 14.6 | 21.5 | |||||||||||||||||||||||||
Other (income) expense, net | (0.1 | ) | 0.5 | 0.1 | (2.3 | ) | 1.3 | (70.7 | ) | 8.4 | (62.8 | ) | |||||||||||||||||||||
Loss on early extinguishment of debt | — | — | — | — | — | — | 3.4 | 3.4 | |||||||||||||||||||||||||
Income tax (benefit) expense | 0.9 | — | — | — | — | 7.3 | 4.4 | 12.6 | |||||||||||||||||||||||||
Noncontrolling interest | 0.1 | 0.1 | — | (1.2 | ) | (1.3 | ) | 17.7 | — | 15.4 | |||||||||||||||||||||||
Bonus to be settled in equity | — | — | — | — | — | — | (0.4 | ) | (0.4 | ) | |||||||||||||||||||||||
Share-based payment expense | — | — | — | 0.1 | 0.1 | — | 0.1 | 0.3 | |||||||||||||||||||||||||
Non-recurring items | 0.9 | — | — | — | — | — | 3.8 | 4.7 | |||||||||||||||||||||||||
Covid-19 Costs | 8.4 | — | — | — | — | — | — | 8.4 | |||||||||||||||||||||||||
Acquisition and disposition costs | 0.2 | — | 0.1 | — | 0.4 | 0.5 | 1.0 | 2.2 | |||||||||||||||||||||||||
Adjusted EBITDA | $ | 19.1 | $ | 4.2 | $ | 0.2 | $ | (4.5 | ) | $ | (1.1 | ) | $ | 0.9 | $ | (3.6 | ) | $ | 15.2 | ||||||||||||||
Total Core Operating Subsidiaries | $ | 23.5 |
RECONCILIATION OF NET INCOME (LOSS) TO ADJUSTED EBITDA
(Unaudited)
(in millions) | Three Months Ended |
||||||||||||||||||||||||||||||||
Core Operating Subsidiaries | Early Stage & Other | Non- operating Corporate |
HC2 | ||||||||||||||||||||||||||||||
Construction | Energy | Telecom | Life Sciences |
Broadcasting | Other and Eliminations |
||||||||||||||||||||||||||||
Net income attributable to |
$ | 9.4 | |||||||||||||||||||||||||||||||
Less: Net income attributable to |
30.3 | ||||||||||||||||||||||||||||||||
Less: Consolidating eliminations attributable to |
(3.2 | ) | |||||||||||||||||||||||||||||||
Net Income (loss) attributable to |
$ | 8.9 | $ | (0.7 | ) | $ | 0.4 | $ | (1.4 | ) | $ | (3.5 | ) | $ | 1.1 | $ | (22.5 | ) | $ | (17.7 | ) | ||||||||||||
Adjustments to reconcile net income (loss) to Adjusted EBITDA: | |||||||||||||||||||||||||||||||||
Depreciation and amortization | 4.0 | 1.5 | 0.1 | 0.1 | 1.5 | — | — | 7.2 | |||||||||||||||||||||||||
Depreciation and amortization (included in cost of revenue) | 2.4 | — | — | — | — | — | — | 2.4 | |||||||||||||||||||||||||
Other operating (income) expenses | — | 0.1 | 0.5 | — | (1.0 | ) | — | — | (0.4 | ) | |||||||||||||||||||||||
Interest expense | 2.2 | 0.5 | — | — | 2.3 | — | 14.5 | 19.5 | |||||||||||||||||||||||||
Net loss (gain) on contingent consideration | — | — | (0.2 | ) | — | — | — | — | (0.2 | ) | |||||||||||||||||||||||
Other (income) expense, net | 0.2 | 0.1 | — | (0.1 | ) | 0.3 | 0.6 | 3.7 | 4.8 | ||||||||||||||||||||||||
Income tax (benefit) expense | 4.1 | — | — | — | 0.1 | — | (4.8 | ) | (0.6 | ) | |||||||||||||||||||||||
Noncontrolling interest | 0.8 | (0.3 | ) | — | (0.5 | ) | (1.0 | ) | 0.8 | — | (0.2 | ) | |||||||||||||||||||||
Share-based payment expense | — | — | — | 0.1 | 0.2 | — | 1.4 | 1.7 | |||||||||||||||||||||||||
Discontinued operations | — | — | — | — | — | 4.9 | 2.8 | 7.7 | |||||||||||||||||||||||||
Non-recurring items | — | — | — | — | — | — | — | — | |||||||||||||||||||||||||
Acquisition and disposition costs | 0.5 | 0.1 | — | — | 0.2 | — | 0.5 | 1.3 | |||||||||||||||||||||||||
Adjusted EBITDA | $ | 23.1 | $ | 1.3 | $ | 0.8 | $ | (1.8 | ) | $ | (0.9 | ) | $ | 7.4 | $ | (4.4 | ) | $ | 25.5 | ||||||||||||||
Total Core Operating Subsidiaries | $ | 25.2 |
RECONCILIATION OF NET INCOME (LOSS) TO ADJUSTED EBITDA
(Unaudited)
(in millions) | Six months ended |
|||||||||||||||||||||||||||||||||
Core Operating Subsidiaries | Early Stage & Other | Total HC2 |
||||||||||||||||||||||||||||||||
Construction | Energy | Telecom | Life Sciences |
Broadcasting | Other & Elimination |
Non- operating Corporate |
||||||||||||||||||||||||||||
Net loss attributable to |
$ | (70.0 | ) | |||||||||||||||||||||||||||||||
Less: Net income attributable to |
11.4 | |||||||||||||||||||||||||||||||||
Less: Consolidating eliminations attributable to |
(3.1 | ) | ||||||||||||||||||||||||||||||||
Net Income (loss) attributable to |
$ | 1.5 | $ | 1.0 | $ | 0.5 | $ | (4.4 | ) | $ | (10.9 | ) | $ | 4.0 | $ | (70.0 | ) | $ | (78.3 | ) | ||||||||||||||
Adjustments to reconcile net income (loss) to Adjusted EBITDA: | ||||||||||||||||||||||||||||||||||
Depreciation and amortization | 5.3 | 4.1 | 0.2 | 0.1 | 3.4 | — | — | 13.1 | ||||||||||||||||||||||||||
Depreciation and amortization (included in cost of revenue) | 4.6 | — | — | — | — | — | — | 4.6 | ||||||||||||||||||||||||||
Other operating (income) expenses | 0.1 | — | — | — | (2.1 | ) | — | — | (2.0 | ) | ||||||||||||||||||||||||
Interest expense | 4.4 | 2.4 | — | — | 6.7 | — | 29.3 | 42.8 | ||||||||||||||||||||||||||
Other (income) expense, net | 0.1 | 0.1 | (0.3 | ) | (2.3 | ) | 2.6 | (71.3 | ) | 6.6 | (64.5 | ) | ||||||||||||||||||||||
Loss on early extinguishment of debt | — | — | — | — | — | — | 9.2 | 9.2 | ||||||||||||||||||||||||||
Income tax (benefit) expense | 1.1 | — | — | — | — | 7.3 | 4.0 | 12.4 | ||||||||||||||||||||||||||
Noncontrolling interest | 0.1 | 0.4 | — | (2.2 | ) | (2.4 | ) | 1.6 | — | (2.5 | ) | |||||||||||||||||||||||
Bonus to be settled in equity | — | — | — | — | — | — | (0.4 | ) | (0.4 | ) | ||||||||||||||||||||||||
Share-based payment expense | — | — | — | 0.1 | 0.2 | — | 1.5 | 1.8 | ||||||||||||||||||||||||||
Discontinued Operations | — | — | — | — | — | 56.3 | 3.8 | 60.1 | ||||||||||||||||||||||||||
Non-recurring items | 1.8 | — | — | — | — | — | 5.2 | 7.0 | ||||||||||||||||||||||||||
Covid-19 costs | 8.8 | — | — | — | — | — | — | 8.8 | ||||||||||||||||||||||||||
Acquisition and disposition costs | 0.3 | — | 0.2 | — | 0.4 | 1.4 | 2.2 | 4.5 | ||||||||||||||||||||||||||
Adjusted EBITDA | $ | 28.1 | $ | 8.0 | $ | 0.6 | $ | (8.7 | ) | $ | (2.1 | ) | $ | (0.7 | ) | $ | (8.6 | ) | $ | 16.6 | ||||||||||||||
Total Core Operating Subsidiaries | $ | 36.7 |
RECONCILIATION OF NET INCOME (LOSS) TO ADJUSTED EBITDA
(Unaudited)
(in millions) | Six months ended |
|||||||||||||||||||||||||||||||||
Core Operating Subsidiaries | Early Stage & Other | Total HC2 |
||||||||||||||||||||||||||||||||
Construction | Energy | Telecom | Life Sciences |
Broadcasting | Other & Elimination |
Non- operating Corporate |
||||||||||||||||||||||||||||
Net income attributable to |
$ | 6.6 | ||||||||||||||||||||||||||||||||
Less: Net income attributable to |
64.1 | |||||||||||||||||||||||||||||||||
Less: Consolidating eliminations attributable to |
(5.5 | ) | ||||||||||||||||||||||||||||||||
Net Income (loss) attributable to |
$ | 11.0 | $ | (1.3 | ) | $ | 1.0 | $ | (4.0 | ) | $ | (7.9 | ) | $ | (4.7 | ) | $ | (46.1 | ) | $ | (52.0 | ) | ||||||||||||
Adjustments to reconcile net income (loss) to Adjusted EBITDA: | ||||||||||||||||||||||||||||||||||
Depreciation and amortization | 7.9 | 2.9 | 0.2 | 0.1 | 2.9 | — | — | 14.0 | ||||||||||||||||||||||||||
Depreciation and amortization (included in cost of revenue) | 4.5 | — | — | — | — | — | — | 4.5 | ||||||||||||||||||||||||||
Other operating (income) expenses | (0.1 | ) | 0.1 | 0.5 | — | (1.9 | ) | — | — | (1.4 | ) | |||||||||||||||||||||||
Interest expense | 4.7 | 0.9 | — | — | 3.9 | — | 28.7 | 38.2 | ||||||||||||||||||||||||||
Net loss (gain) on contingent consideration | — | — | (0.2 | ) | — | — | — | — | (0.2 | ) | ||||||||||||||||||||||||
Other (income) expense, net | 0.2 | 0.2 | — | (0.1 | ) | 0.4 | (0.2 | ) | 1.0 | 1.5 | ||||||||||||||||||||||||
Income tax (benefit) expense | 5.1 | — | — | — | 0.1 | — | (2.5 | ) | 2.7 | |||||||||||||||||||||||||
Noncontrolling interest | 0.9 | (0.6 | ) | — | (0.8 | ) | (1.6 | ) | (1.6 | ) | — | (3.7 | ) | |||||||||||||||||||||
Share-based payment expense | — | — | — | 0.1 | 0.4 | — | 2.5 | 3.0 | ||||||||||||||||||||||||||
Discontinued operations | — | — | — | — | — | 9.0 | 5.3 | 14.3 | ||||||||||||||||||||||||||
Non-recurring items | — | — | — | — | — | — | — | — | ||||||||||||||||||||||||||
Acquisition and disposition costs | 1.3 | 0.1 | 0.1 | — | 0.3 | — | 0.6 | 2.4 | ||||||||||||||||||||||||||
Adjusted EBITDA | $ | 35.5 | $ | 2.3 | $ | 1.6 | $ | (4.7 | ) | $ | (3.4 | ) | $ | 2.5 | $ | (10.5 | ) | $ | 23.3 | |||||||||||||||
Total Core Operating Subsidiaries | $ | 39.4 |
RECONCILIATION OF NET INCOME (LOSS) TO ADJUSTED OPERATING INCOME ("INSURANCE AOI")
AND PRE-TAX OPERATING INCOME ("PRE-TAX INSURANCE AOI")
(Unaudited)
The table below shows the adjustments made to the reported Net income (loss) of the Insurance segment to calculate Insurance AOI and Pre-tax Insurance AOI.
(in millions) | Three Months Ended |
Six Months Ended |
||||||||||||||||||||||
2020 | 2019 | Increase / (Decrease) |
2020 | 2019 | Increase / (Decrease) |
|||||||||||||||||||
Net income - Insurance segment | $ | 11.4 | $ | 30.3 | $ | (18.9 | ) | $ | 11.4 | $ | 64.1 | $ | (52.7 | ) | ||||||||||
Effect of investment losses (gains) (1) | 0.4 | 0.5 | (0.1 | ) | 19.4 | (5.5 | ) | 24.9 | ||||||||||||||||
Gain on bargain purchase | — | (1.1 | ) | 1.1 | — | (1.1 | ) | 1.1 | ||||||||||||||||
Acquisition costs | — | 1.6 | (1.6 | ) | — | 1.8 | (1.8 | ) | ||||||||||||||||
Insurance AOI | 11.8 | 31.3 | (19.5 | ) | 30.8 | 59.3 | (28.5 | ) | ||||||||||||||||
Income tax expense (benefit) | 2.8 | 1.7 | 1.1 | (9.6 | ) | 2.4 | (12.0 | ) | ||||||||||||||||
Pre-tax Insurance AOI | $ | 14.6 | $ | 33.0 | $ | (18.4 | ) | $ | 21.2 | $ | 61.7 | $ | (40.5 | ) |
(1) The Insurance segment results are inclusive of realized and unrealized gains and net investment income for the three and six months ended
Source: HC2 Holdings, Inc.